[1]
C. Massimetti, A. Bellasi, and S. Feriozzi, “Effects of secondary hyperparathyroidism treatment on hemoglobin levels and erythropoietin doses in hemodialysis patients”,
J Clini Nephrol
, vol. 5, no. 3, pp. 088–094, Oct. 2021.